The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study
Open accessAbstract
BACKGROUND: Little or no research has determined the effect of vitamin D3 supplementation in conjunction with pharmacological and non-pharmacological approaches in the diabetes mellitus type 2 (DMT2) patients. The objective of this study was to determine the effect of vitamin D3 supplementation in a cohort of Saudi DMT2 population on diet, insulin and/or different oral hypoglycemic agents and compare them with a non-DMT2 control cohort. METHODS: A total of 499 randomly selected Saudi subjects divided into 8 groups [Non-DMT2 Control = 151; Rosiglitazone alone = 49; Diet = 15; Insulin alone = 55; Insulin + Orals = 12; Metformin alone = 121; Oral agents combination = 37; Sulphonylurea alone = 59] were included in this 12-month interventional study. All DMT2 patients were given 2000 IU vitamin D3 daily, while the control group received none but were advised to increase sun exposure. Anthropometrics, glucose, lipid profile and 25-hydroxyvitamin D (25-OHVitD) were measured at baseline, 6 and 12 months. RESULTS: Circulating 25-OHVitD concentrations improved in all patient groups. The metformin group showed the highest change in circulating vitamin D levels both at 6 months (62.6%) and 12 months (50.6%) as compared to baseline (p < 0.001). No significant changes were observed in the BMI and glucose in any of the DMT2 groups. In contrast, the insulin + oral agents group showed more significant improvements in the metabolic profile, which included triglycerides and total cholesterol, as well as systolic blood pressure and HDL-cholesterol in males. Also, significant decreases in triglycerides were observed in the rosiglitazone and insulin + oral hypoglycemic agent groups both at 6 and 12 months of supplementation (both p-values <0.001). CONCLUSION: While in all DMT2 groups circulating levels of 25-OHVitD increased after supplementation, in DMT2 patients on insulin in combination with other drugs benefitted the most in improving cardiovascular risk. Metformin improves 25-hydroxyvitamin D levels but did not seem to confer other added cardiometabolic benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global vitamin D status and determinants of hypovitaminosis D
on behalf of the IOF Committee of Scientific Advisors (CSA) Nutrition Working Group, Mithal, A., Wahl, D. A., Bonjour, J.-P., Burckhardt, P., Dawson-Hughes, B., Eisman, J. A., El-Hajj Fuleihan, G., Josse, R. G., Lips, P., et al. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0954-6 · Cited by 1,472
Vitamin D deficiency: a global perspective: Nutrition Reviews©, Vol. 66, No. s2
Prentice, A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00100.x · Cited by 489 · cited 1×
“Background Vitamin D deficiency has been a global pandemic for a while [1,2], yet the level of attention given by the scientific and clinical community was only recently stimulated, primarily because of the pleiotropic effects of this hormone outside the skeletal system.”
BackgroundSerum 25-Hydroxyvitamin D Concentration and Subsequent Risk of Type 2 Diabetes
Mattila, C., Knekt, P., Männistö, S., Rissanen, H., Laaksonen, M. A., Montonen, J., & Reunanen, A. (2007) · Diabetes Care · doi:10.2337/dc07-0292 · Cited by 336
Al-Daghri, N. M., Al-Attas, O. S., Alokail, M. S., Alkharfy, K. M., Yousef, M., Sabico, S. L., & Chrousos, G. P. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-76 · Cited by 282 · cited 6×
“All measurements were done in a DEQAS- (Vitamin D External Quality Assessment Scheme) participating laboratory, the Biomarkers Research Program (BRP) of King Saud University, Riyadh, KSA.”
BackgroundInfluentialSelf-citationWood, A. D., Secombes, K. R., Thies, F., Aucott, L., Black, A. J., Mavroeidi, A., Simpson, W. G., Fraser, W. D., Reid, D. M., & Macdonald, H. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2126 · Cited by 185 · cited 1×
“However, the improvement in the cholesterol levels secondary to vitamin D correction were not observed in other trials involving the general population in both the short- and long term [17,18].”
BackgroundYiu, Y.-F., Yiu, K.-H., Siu, C.-W., Chan, Y.-H., Li, S.-W., Wong, L.-Y., Lee, S. W. L., Tam, S., Wong, E. W. K., Lau, C.-P., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.013 · Cited by 182
Middle East and North Africa consensus on osteoporosis.
Maalouf, G., Gannagé‐Yared, M., Ezzedine, J., Larijani, B. A., Badawi, S., Rached, A., Zakroui, L., Masri, B. K., Azar, E., Saba, E., et al. (2007) · PubMed · Cited by 158
Self-citationBreslavsky, A., Frand, J., Matas, Z., Boaz, M., Barnea, Z., & Shargorodsky, M. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.01.020 · Cited by 152 · cited 1×
“The significant improvements in the metabolic status of DMT2 subjects secondary to vitamin D supplementation have also been documented in other interventional and clinical trial studies with respect to glucose homeostasis, although beneficial effects in vascular function fell short [11,12].”
BackgroundRole of Vitamin D in the Development of Insulin Resistance and Type 2 Diabetes
Pilz, S., Kienreich, K., Rutters, F., de Jongh, R. T., van Ballegooijen, A. J., Grübler, M. R., Tomaschitz, A., & Dekker, J. M. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0358-4 · Cited by 144 · cited 1×
“A recent review by Pilz and colleagues observed that the modest effects of vitamin D on glycemic control and insulin resistance in a few randomized controlled trials are insufficient to recommend vitamin D supplementation for DMT2 patients [13].”
BackgroundEFFECTS OF THERAPY ON PLASMA-HIGH-DENSITY-LIPOPROTEIN-CHOLESTEROL CONCENTRATION IN DIABETES MELLITUS
Calvert, G. D., Mannik, T., Graham, J. J., Wise, P. H., & Yeates, R. A. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91380-6 · Cited by 142 · cited 1×
“mention the lower ability of sulphonylureas to improve the lipid profile, making it a positive risk factor for ischemic heart disease in patients with DMT2 [20-23].”
Background
Research works printed but not linked: 1
- 10.2337/diabetes.46.10.1601 · DOI
Cited by
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Martín-Timón, I. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.444 · Cited by 976
Vitamins and Type 2 Diabetes Mellitus
Valdes-Ramos, R., Laura, G.-L., Elina, M.-C., & Donaji, B.-A. (2015) · Endocrine, Metabolic & Immune Disorders-Drug Targets · doi:10.2174/1871530314666141111103217 · Cited by 185
Natural Nrf2 activators in diabetes
Jiménez‐Osorio, A. S., González-Reyes, S., & Pedraza‐Chaverrí, J. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.07.009 · Cited by 161
Vitamin D in Saudi Arabia: Prevalence,distribution and disease associations
Al‐Daghri, N. M. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.12.017 · Cited by 115
Self-citation
Metadata
- Authors
- Alkharfy, K. M., Al-Daghri, N. M., Sabico, S. B., Al-Othman, A., Moharram, O., Alokail, M. S., Al-Saleh, Y., Kumar, S., & Chrousos, G. P.
- Affiliations
- King Saud University (SA)
- University Hospital Coventry (GB)
- National and Kapodistrian University of Athens (GR)
- Corresponding author
- Alkharfy, Khalid M
- Venue
- Cardiovascular Diabetology
- Published
- 2013
- Volume
- 12
- Issue
- 1
- Pages
- 113
- ISSN
- 1475-2840 (ISSN-L)
- PMC
- PMC3750473
- OpenAlex
- W1981230812
- Cited by
- 47
- References
- 24
- Citations by year
- 2024: 3 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 11 · 2014: 11
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Cardiovascular Diabetology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- vitamin D3 supplementation, type 2 diabetes, 25-hydroxyvitamin D, metformin, insulin therapy, oral antidiabetic drugs, rosiglitazone, sulfonylureas, triglycerides, cardiovascular risk, lipid profile, sun exposure, Saudi patients
- MeSH terms
- Rosiglitazone, Administration, Oral, Adult, Blood Glucose, Cholecalciferol, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Female, Humans, Hypoglycemic Agents, Insulin, Lipids, Male, Metformin, Middle Aged, Prospective Studies, Saudi Arabia, Sulfonylurea Compounds, Vitamin D, Biomarkers, Case-Control Studies, Treatment Outcome, Dietary Supplements, Thiazolidinediones, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study. https://app.cochat.ai/papers/10.1186/1475-2840-12-113
- The paper
- Alkharfy, K. M., Al-Daghri, N. M., Sabico, S. B., Al-Othman, A., Moharram, O., Alokail, M. S., Al-Saleh, Y., Kumar, S., & Chrousos, G. P. (2013). Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study. Cardiovascular Diabetology. https://doi.org/10.1186/1475-2840-12-113
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
